Introduction: The impact of body mass index (BMI) on outcomes after mechanical thrombectomy (MT) for large vessel occlusion acute ischemic stroke (LVOS) has been a subject of controversy, mainly due to the so-called obesity paradox. The obesity paradox refers to the phenomenon where, contrary to expectations, overweight or obese individuals seem to have better clinical outcomes in certain disease states. This study aimed to investigate the relationship between BMI and the clinical prognosis of patients with LVOS treated with endovascular thrombectomy (EVT) combined with or without intravenous alteplase in DIRECT-MT (Direct Intra-arterial Thrombectomy to Revascularize Acute Ischemic Stroke Patients with Large Vessel Occlusion Efficiently in Chinese Tertiary Hospitals: A Multicenter Randomized Clinical Trial). Methods: This is a post hoc analysis of the DIRECT-MT randomized trial. Patients were randomly allocated to undergo EVT after alteplase intravenous thrombolysis (IVT) (IVT+EVT group) or EVT alone (EVT group) at a 1:1 ratio. Among 656 randomized patients, 645 with baseline BMI information were included. The BMI was analyzed as a categorical variable, and all patients were categorized according to their BMI into 3 groups: 18.5 ≤ BMI <24 kg/m2 (normal weight), 24 ≤ BMI <28 kg/m2 (overweight), and BMI ≥28 kg/m2 (obese). The primary outcome was the 90-day modified Rankin Scale (mRS) score analyzed as a continuous variable. Multivariable ordinal logistic regression with an interaction term was used to estimate treatment allocation and the BMI subgroups. Results: A total of 645 patients were enrolled in this study, 373 (57.8%) were normal weight, 208 (32.2%) were overweight, and 64 (10.0%) were obese. In all, 175 (46.9%) normal-weight patients, 114 (54.8%) overweight patients, and 31 (48.4%) obese patients underwent direct EVT. Patients in the three groups were statistically different in age (71 versus 68, 66), time from randomization to groin puncture (31 versus 32, 39.5), time from randomization to revascularization (101.5 versus 92, 116), and time from admission to groin puncture (84 versus 83, 98.5). Other baseline and procedural characteristics were comparable. No significant difference for the ordinal mRS or 90-day mortality was observed by BMI (adjusted common odds ratio [acOR] was 0.92 [95% CI 0.64 to 1.32] for normal weight, 1.36 [95% CI 0.83 to 2.22] for overweight, and 1.09 [95% CI 0.45 to 2.64] for obese) and treatment allocation interaction (the adjusted p value for interaction was 0.335 [normal weight versus overweight], 0.761 [normal weight versus obese], and 0.733 [overweight versus obese]). For the procedural complications and other clinical and imaging outcomes, no significant differences were observed between the BMI and treatment allocation. Conclusion: The results demonstrated that BMI had no association with the final outcome whether the patient with LVOS underwent EVT alone or plus IVT for Chinese adults. Thus, the obesity paradox does not appear to pertain to EVT alone or plus IVT. Further studies are needed to confirm the finding.

Journal Section:
Clinical Research in Stroke
Keywords:
Body mass index, Endovascular thrombectomy, Intravenous alteplase, Stroke
1.
Feigin
VL
,
Stark
BA
,
Johnson
CO
,
Roth
GA
,
Bisignano
C
,
Abady
GG
, et al.
Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
.
The Lancet Neurol
.
2021
;
20
(
10
):
795
–
820
.
Google Scholar
PubMed
 
2.
Strazzullo
P
,
D'Elia
L
,
Cairella
G
,
Garbagnati
F
,
Cappuccio
FP
,
Scalfi
L
.
Excess body weight and incidence of stroke: meta-analysis of prospective studies with 2 million participants
.
Stroke
.
2010
;
41
(
5
):
e418
–
26
.
Google Scholar
PubMed
 
3.
Qi
W
,
Ma
J
,
Guan
T
,
Zhao
D
,
Abu-Hanna
A
,
Schut
M
, et al.
Risk factors for incident stroke and its subtypes in China: a prospective study
.
J Am Heart Assoc
.
2020
;
9
(
21
):
e016352
.
Google Scholar
PubMed
 
4.
Liu
Z
,
Sanossian
N
,
Starkman
S
,
Avila-Rinek
G
,
Eckstein
M
,
Sharma
LK
, et al.
Adiposity and outcome after ischemic stroke: obesity paradox for mortality and obesity parabola for favorable functional outcomes
.
Stroke
.
2021
;
52
(
1
):
144
–
51
.
Google Scholar
PubMed
 
5.
Rozen
G
,
Elbaz-Greener
G
,
Margolis
G
,
Marai
I
,
Heist
EK
,
Ruskin
JN
, et al.
The obesity paradox in real-world nation-wide cohort of patients admitted for a stroke in the U.S
.
J Clin Med
.
2022
;
11
(
6
):
1678
.
Google Scholar
PubMed
 
6.
Persaud
SR
,
Lieber
AC
,
Donath
E
,
Stingone
JA
,
Dangayach
NS
,
Zhang
X
, et al.
Obesity paradox in intracerebral hemorrhage
.
Stroke
.
2019
;
50
(
4
):
999
–
1002
.
Google Scholar
PubMed
 
7.
Pirson
FAV
,
Hinsenveld
WH
,
Staals
J
,
de Greef
BTA
,
van Zwam
WH
,
Dippel
DWJ
, et al.
The effect of body mass index on outcome after endovascular treatment in acute ischemic stroke patients: a post hoc analysis of the MR CLEAN trial
.
Cerebrovasc Dis
.
2019
;
48
(
3–6
):
200
–
6
.
Google Scholar
PubMed
 
8.
Andersen
KK
,
Olsen
TS
.
The obesity paradox in stroke: lower mortality and lower risk of readmission for recurrent stroke in obese stroke patients
.
Int J Stroke
.
2015
;
10
(
1
):
99
–
104
.
Google Scholar
PubMed
 
9.
Chen
SH
,
McCarthy
D
,
Saini
V
,
Brunet
MC
,
Peterson
EC
,
Yavagal
D
, et al.
Effect of body mass index on outcomes of mechanical thrombectomy in acute ischemic stroke
.
World Neurosurg
.
2020
;
143
:
e503
–
15
.
Google Scholar
PubMed
 
10.
Gensicke
H
,
Wicht
A
,
Bill
O
,
Zini
A
,
Costa
P
,
Kägi
G
, et al.
Impact of body mass index on outcome in stroke patients treated with intravenous thrombolysis
.
Eur J Neurol
.
2016
;
23
(
12
):
1705
–
12
.
Google Scholar
PubMed
 
11.
Dehlendorff
C
,
Andersen
KK
,
Olsen
TS
.
Body mass index and death by stroke: no obesity paradox
.
JAMA Neurol
.
2014
;
71
(
8
):
978
–
84
.
Google Scholar
PubMed
 
12.
Scherbakov
N
,
Dirnagl
U
,
Doehner
W
.
Body weight after stroke: lessons from the obesity paradox
.
Stroke
.
2011
;
42
(
12
):
3646
–
50
.
Google Scholar
PubMed
 
13.
Doehner
W
,
Clark
A
,
Anker
SD
.
The obesity paradox: weighing the benefit
.
Eur Heart J
.
2010
;
31
(
2
):
146
–
8
.
Google Scholar
PubMed
 
14.
Elagizi
A
,
Kachur
S
,
Lavie
CJ
,
Carbone
S
,
Pandey
A
,
Ortega
FB
, et al.
An overview and update on obesity and the obesity paradox in cardiovascular diseases
.
Prog Cardiovasc Dis
.
2018
;
61
(
2
):
142
–
50
.
Google Scholar
PubMed
 
15.
Hong
NS
,
Kim
KS
,
Lee
IK
,
Lind
PM
,
Lind
L
,
Jacobs
DR
, et al.
The association between obesity and mortality in the elderly differs by serum concentrations of persistent organic pollutants: a possible explanation for the obesity paradox
.
Int J Obes
.
2012
;
36
(
9
):
1170
–
5
.
Google Scholar
 
16.
Ozeke
O
,
Ozer
C
,
Gungor
M
,
Celenk
MK
,
Dincer
H
,
Ilicin
G
.
Chronic intermittent hypoxia caused by obstructive sleep apnea may play an important role in explaining the morbidity-mortality paradox of obesity
.
Med Hypotheses
.
2011
;
76
(
1
):
61
–
3
.
Google Scholar
PubMed
 
17.
Hacke
W
,
Kaste
M
,
Fieschi
C
,
von Kummer
R
,
Davalos
A
,
Meier
D
, et al.
Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators
.
Lancet
.
1998
;
352
(
9136
):
1245
–
51
.
Google Scholar
PubMed
 
18.
Turc
G
,
Tsivgoulis
G
,
Audebert
HJ
,
Boogaarts
H
,
Bhogal
P
,
De Marchis
GM
, et al.
European Stroke Organisation (ESO)-European Society for Minimally Invasive Neurological Therapy (ESMINT) expedited recommendation on indication for intravenous thrombolysis before mechanical thrombectomy in patients with acute ischemic stroke and anterior circulation large vessel occlusion
.
J Neurointerv Surg
.
2022
;
14
(
3
):
209
.
Google Scholar
PubMed
 
19.
Yang
P
,
Zhang
Y
,
Zhang
L
,
Zhang
Y
,
Treurniet
KM
,
Chen
W
, et al.
Endovascular thrombectomy with or without intravenous alteplase in acute stroke
.
N Engl J Med
.
2020
;
382
(
21
):
1981
–
93
.
Google Scholar
PubMed
 
20.
Yang
P
,
Treurniet
KM
,
Zhang
L
,
Zhang
Y
,
Li
Z
,
Xing
P
, et al.
Direct Intra-arterial thrombectomy in order to revascularize AIS patients with large vessel occlusion Efficiently in Chinese Tertiary hospitals: a multicenter randomized clinical trial (DIRECT-MT)-Protocol
.
Int J Stroke
.
2020
;
15
(
6
):
689
–
98
.
Google Scholar
PubMed
 
21.
Hsu
WC
,
Araneta
MRG
,
Kanaya
AM
,
Chiang
JL
,
Fujimoto
W
.
BMI cut points to identify at-risk Asian Americans for type 2 diabetes screening
.
Diabetes Care
.
2015
;
38
(
1
):
150
–
8
.
Google Scholar
PubMed
 
22.
Zhou
BF
.
Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults: study on optimal cut-off points of body mass index and waist circumference in Chinese adults
.
Biomed Environ Sci
.
2002
;
15
(
1
):
83
–
96
.
Google Scholar
PubMed
 
23.
Zeng
Q
,
He
Y
,
Dong
S
,
Zhao
X
,
Chen
Z
,
Song
Z
, et al.
Optimal cut-off values of BMI, waist circumference and waist:height ratio for defining obesity in Chinese adults
.
Br J Nutr
.
2014
;
112
(
10
):
1735
–
44
.
Google Scholar
PubMed
 
24.
von Kummer
R
,
Broderick
JP
,
Campbell
BCV
,
Demchuk
A
,
Goyal
M
,
Hill
MD
, et al.
The Heidelberg bleeding classification: classification of bleeding events after ischemic stroke and reperfusion therapy
.
Stroke
.
2015
;
46
(
10
):
2981
–
6
.
Google Scholar
PubMed
 
25.
Bardugo
A
,
Fishman
B
,
Libruder
C
,
Tanne
D
,
Ram
A
,
Hershkovitz
Y
, et al.
Body mass index in 1.9 million adolescents and stroke in young adulthood
.
Stroke
.
2021
;
52
(
6
):
2043
–
52
.
Google Scholar
PubMed
 
26.
Bouslama
M
,
Perez
HJ
,
Barreira
CM
,
Haussen
DC
,
Grossberg
JA
,
Belagaje
SR
, et al.
Body mass index and clinical outcomes in large vessel occlusion acute ischemic stroke after endovascular therapy
.
Interv Neurol
.
2020
;
8
(
2–6
):
144
–
51
.
Google Scholar
PubMed
 
27.
Deng
Q
,
Zhang
L
,
Liu
Y
,
Zhou
F
,
Yuan
Z
,
Wang
X
, et al.
Effect of time window on endovascular thrombectomy with or without intravenous thrombolysis in acute ischemic stroke: results from DIRECT-MT
.
Cerebrovasc Dis
.
2024
;
53
(
2
):
176
–
83
.
Google Scholar
Crossref
Search ADS
PubMed
 
© 2025 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2025
You do not currently have access to this content.